Patent · US Active

Drug carriers

US8003621B2 · kind B2 · utility

11Cited by

224References

26Claims

0Family size

Assignee

NITTO DENKO CORPORATION · JP

Inventors

Yoshiro Niitsu · Sapporo, JP
Lei Yu · Huangguan, CN
Jian Liu · Los Angeles, US
Gang Zhao · Oceanside, US
Nianchun Ma · Oceanside, US
Sang Van · San Diego, US

Key dates

Filing date	Sep 12, 2008
Grant date	Aug 23, 2011
Priority date	—
Expiry date	Sep 12, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions that can include a cationic polymeric carrier, targeting agent, and therapeutic agent are disclosed herein. The therapeutic agent may have a therapeutic activity such as inhibiting fibrosis within a target organ or tissue or inhibiting the growth of a cancer cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.